Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

Lagevrio (molnupiravir) - Ridgeback Biotherap, Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/41423550

Aimin Yang; Carrie Ho Kwan Yam; Chi Tim Hung; Chris Ka Pun Mok; Christopher Boyer; Conglu Li; David Sc Hui; Eng Kiong Yeoh; Guozhang Lin; Huwen Wang; Ka Chun Chong; Katherine Min Jia; Kehang Li; Shi Zhao; Tsz Yu Chow; Yuchen Wei; Zihao Guo

Dec 22, 2025